Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
UW26004: Phase I Trial of Allogeneic iNKT Cell Therapy (agenT-797) in Patients Undergoing Allogeneic Hematological Stem Cell Transplantation (SCT)
The goal of this clinical trial is to learn if agenT-797 is safe to use on people undergoing allogenic hematological stem cell transplantation (SCT). The main …
Allogenic Stem Cell TransplantationMyeloid MalignanciesLymphoid Malignancies+3 more
Estimated
~$10 – $6,250
University of Wisconsin, MadisonNCT07758218
Phase 1
An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 a…
Lymphoid Malignancies
Estimated
~$10 – $8,750
AVM Biotechnology IncNCT04329728
Phase 1
Feasibility Study of CD34 Selection for GVHD Prophylaxis Using the Automated CliniMACS
Patients with graft failure or delayed engraftment may benefit from a hematopoietic stem cell boost or an additional hematopoietic stem cell transplantation pr…
AMLALLLymphoid Malignancies+3 more
Estimated
~$10 – $6,250
University of Alabama at BirminghamNCT06047886